ArticleCancers2020

An Integrated Genomic Strategy to Identify CHRNB4 as a Diagnostic/Prognostic Biomarker for Targeted Therapy in Head and Neck Cancer.

Yi-Hsuan Chuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.